530 related articles for article (PubMed ID: 31116032)
1. Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention.
Urban P; Mehran R; Colleran R; Angiolillo DJ; Byrne RA; Capodanno D; Cuisset T; Cutlip D; Eerdmans P; Eikelboom J; Farb A; Gibson CM; Gregson J; Haude M; James SK; Kim HS; Kimura T; Konishi A; Laschinger J; Leon MB; Magee PFA; Mitsutake Y; Mylotte D; Pocock S; Price MJ; Rao SV; Spitzer E; Stockbridge N; Valgimigli M; Varenne O; Windhoevel U; Yeh RW; Krucoff MW; Morice MC
Circulation; 2019 Jul; 140(3):240-261. PubMed ID: 31116032
[TBL] [Abstract][Full Text] [Related]
2. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.
Urban P; Mehran R; Colleran R; Angiolillo DJ; Byrne RA; Capodanno D; Cuisset T; Cutlip D; Eerdmans P; Eikelboom J; Farb A; Gibson CM; Gregson J; Haude M; James SK; Kim HS; Kimura T; Konishi A; Laschinger J; Leon MB; Magee PFA; Mitsutake Y; Mylotte D; Pocock S; Price MJ; Rao SV; Spitzer E; Stockbridge N; Valgimigli M; Varenne O; Windhoevel U; Yeh RW; Krucoff MW; Morice MC
Eur Heart J; 2019 Aug; 40(31):2632-2653. PubMed ID: 31116395
[TBL] [Abstract][Full Text] [Related]
3. Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document.
Garot P; Morice MC; Angiolillo DJ; Cabau JR; Park DW; Van Mieghem NM; Collet JP; Leon MB; Sengottuvelu G; Neylon A; Ten Berg JM; Mylotte D; Tchétché D; Krucoff MW; Reardon MJ; Piazza N; Mack MJ; Généreux P; Makkar R; Hayashida K; Ohno Y; Mochizuki S; Shirai Y; Matsumara R; Jin Y; Webb JG; Cutlip DE; Chen M; Spitzer E; Mehran R; Capodanno D
EuroIntervention; 2024 May; 20(9):536-550. PubMed ID: 38726720
[TBL] [Abstract][Full Text] [Related]
4. Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.
Natsuaki M; Morimoto T; Shiomi H; Yamaji K; Watanabe H; Shizuta S; Kato T; Ando K; Nakagawa Y; Furukawa Y; Tada T; Nagao K; Kadota K; Toyofuku M; Kimura T
Circ Cardiovasc Interv; 2019 Nov; 12(11):e008307. PubMed ID: 31707804
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients.
Cao D; Mehran R; Dangas G; Baber U; Sartori S; Chandiramani R; Stefanini GG; Angiolillo DJ; Capodanno D; Urban P; Morice MC; Krucoff M; Goel R; Roumeliotis A; Sweeny J; Sharma SK; Kini A
J Am Coll Cardiol; 2020 Jun; 75(21):2711-2722. PubMed ID: 32466887
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores.
Ueki Y; Bär S; Losdat S; Otsuka T; Zanchin C; Zanchin T; Gragnano F; Gargiulo G; Siontis GCM; Praz F; Lanz J; Hunziker L; Stortecky S; Pilgrim T; Heg D; Valgimigli M; Windecker S; Räber L
EuroIntervention; 2020 Aug; 16(5):371-379. PubMed ID: 32065586
[TBL] [Abstract][Full Text] [Related]
7. Sex-Based Differences in Bleeding Risk After Percutaneous Coronary Intervention and Implications for the Academic Research Consortium High Bleeding Risk Criteria.
Spirito A; Gragnano F; Corpataux N; Vaisnora L; Galea R; Svab S; Gargiulo G; Siontis GCM; Praz F; Lanz J; Billinger M; Hunziker L; Stortecky S; Pilgrim T; Capodanno D; Urban P; Pocock S; Mehran R; Heg D; Windecker S; Räber L; Valgimigli M
J Am Heart Assoc; 2021 Jun; 10(12):e021965. PubMed ID: 34098740
[TBL] [Abstract][Full Text] [Related]
8. Applicability of the Academic Research Consortium for High Bleeding Risk in acute coronary syndrome undergoing percutaneous coronary intervention.
Abu-Assi E; Raposeiras-Roubín S; Cespón Fernández M; Caneiro Queija B; Melendo Viu M; Íñiguez Romo A
Rev Esp Cardiol (Engl Ed); 2022 May; 75(5):375-383. PubMed ID: 33865751
[TBL] [Abstract][Full Text] [Related]
9. Development and assessment of total thrombus-formation analysis system-based bleeding risk model in patients undergoing percutaneous coronary intervention.
Nakanishi N; Kaikita K; Ishii M; Kuyama N; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Kanazawa H; Hanatani S; Sueta D; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Soejima H; Matsushita K; Tsujita K
Int J Cardiol; 2021 Feb; 325():121-126. PubMed ID: 33053391
[TBL] [Abstract][Full Text] [Related]
10. Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel.
Capodanno D; Morice MC; Angiolillo DJ; Bhatt DL; Byrne RA; Colleran R; Cuisset T; Cutlip D; Eerdmans P; Eikelboom J; Farb A; Gibson CM; Gregson J; Haude M; James SK; Kim HS; Kimura T; Konishi A; Leon MB; Magee PFA; Mitsutake Y; Mylotte D; Pocock SJ; Rao SV; Spitzer E; Stockbridge N; Valgimigli M; Varenne O; Windhovel U; Krucoff MW; Urban P; Mehran R
J Am Coll Cardiol; 2020 Sep; 76(12):1468-1483. PubMed ID: 32943165
[TBL] [Abstract][Full Text] [Related]
11. Implications and characteristics of high bleeding risk in East Asian patients undergoing percutaneous coronary intervention: Start with what is right rather than what is acceptable.
Nakamura M; Iijima R
J Cardiol; 2021 Aug; 78(2):91-98. PubMed ID: 33358236
[TBL] [Abstract][Full Text] [Related]
12. An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry.
Rao SV; McCoy LA; Spertus JA; Krone RJ; Singh M; Fitzgerald S; Peterson ED
JACC Cardiovasc Interv; 2013 Sep; 6(9):897-904. PubMed ID: 24050858
[TBL] [Abstract][Full Text] [Related]
13. Comparison of original and modified Academic Research Consortium for High Bleeding Risk definitions in real-world practice.
Takahashi K; Miura K; Shima Y; Okabe K; Ikuta A; Taguchi Y; Ohya M; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
J Cardiol; 2022 Aug; 80(2):155-161. PubMed ID: 35282943
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.
Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP
Circulation; 2018 Jul; 138(5):527-536. PubMed ID: 30571525
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of the Academic Research Consortium high bleeding risk criteria in patients undergoing endovascular therapy for peripheral artery disease in lower extremities.
Hashimoto R; Numasawa Y; Yokokura S; Daigo K; Sakata S; Imaeda S; Hitomi Y; Sato K; Taruoka A; Haginiwa S; Kojima H; Tanaka M; Kuno T; Kodaira M
Heart Vessels; 2021 Sep; 36(9):1350-1358. PubMed ID: 33651134
[TBL] [Abstract][Full Text] [Related]
16. Impact of in-hospital bleeding according to the Bleeding Academic Research Consortium classification on the long-term adverse outcomes in patients undergoing percutaneous coronary intervention.
Yoon YH; Kim YH; Kim SO; Lee JY; Park DW; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2015 Jan; 85(1):63-71. PubMed ID: 24282105
[TBL] [Abstract][Full Text] [Related]
17. Simplified Academic Research Consortium for High Bleeding Risk (ARC-HBR) Definition Predicts Bleeding Events in Patients With Heart Failure.
Sato Y; Yoshihisa A; Takeishi R; Ohara H; Sugawara Y; Ichijo Y; Hotsuki Y; Watanabe K; Abe S; Misaka T; Sato T; Oikawa M; Kobayashi A; Nakazato K; Takeishi Y
Circ J; 2021 Dec; 86(1):147-155. PubMed ID: 34707066
[TBL] [Abstract][Full Text] [Related]
18. Validation of the ARC-HBR criteria in 68,874 patients undergoing PCI: A systematic review and meta-analysis.
Montalto C; Munafò AR; Arzuffi L; Casula M; Mandurino-Mirizzi A; Costa F; Leonardi S; Oltrona Visconti L; Ferlini M
Hellenic J Cardiol; 2022; 66():59-66. PubMed ID: 35550178
[TBL] [Abstract][Full Text] [Related]
19. Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk.
Corpataux N; Spirito A; Gragnano F; Vaisnora L; Galea R; Svab S; Gargiulo G; Zanchin T; Zanchin C; Siontis GCM; Praz F; Lanz J; Hunziker L; Stortecky S; Pilgrim T; Räber L; Capodanno D; Urban P; Pocock S; Heg D; Windecker S; Valgimigli M
Eur Heart J; 2020 Oct; 41(38):3743-3749. PubMed ID: 33029615
[TBL] [Abstract][Full Text] [Related]
20. Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients).
Baber U; Li SX; Pinnelas R; Pocock SJ; Krucoff MW; Ariti C; Gibson CM; Steg PG; Weisz G; Witzenbichler B; Henry TD; Kini AS; Stuckey T; Cohen DJ; Iakovou I; Dangas G; Aquino MB; Sartori S; Chieffo A; Moliterno DJ; Colombo A; Mehran R
Circ Cardiovasc Interv; 2018 Mar; 11(3):e006144. PubMed ID: 29870385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
